ストックスクリーナーアプリを入手
16.12
1.76%
0.24
Novocure Ltd (NVCR) 最新ニュース
Why NovoCure (NVCR) Is Up 33.2% After FDA Clears Optune Pax And Guidance Ticks Higher - Sahm
Wells Fargo Maintains Novocure(NVCR.US) With Hold Rating, Raises Target Price to $17 - Moomoo
NovoCure’s Optune Pax Win And TRIDENT Data Shape Growth Outlook - Sahm
NovoCure Limited Surges As Guidance Hike Fuels NVCR Rally - timothysykes.com
Here's What Analysts Are Forecasting For NovoCure Limited (NASDAQ:NVCR) After Its First-Quarter Results - Moomoo
NovoCure Limited (NASDAQ:NVCR) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance
NovoCure Reports Q1 2026 Results: Full Earnings Call Transcript - Sahm
NovoCure Ltd (NVCR) Shares Surge 9.3% -- What GF Score of 70 Tel - GuruFocus
NovoCure (NASDAQ:NVCR) Trading 6.8% HigherShould You Buy? - MarketBeat
NVCR Maintained by Evercore ISI Group -- Price Target Raised to $20 - GuruFocus
Evercore Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $20 - Moomoo
NovoCure Ltd (NVCR) Q1 2026 Earnings Call Highlights: Revenue Gr - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
NovoCure (NVCR) Earnings Story Centers On 20.6% Revenue Growth Versus Ongoing Losses - simplywall.st
MSN Money - MSN
NovoCure Earnings Call Highlights Growth, One-Time Hit - TipRanks
NovoCure Limited Q1 2026 Earnings Call Summary - Yahoo Finance
NovoCure (NASDAQ:NVCR) Announces Earnings Results - MarketBeat
NovoCure Ltd Q1 2026 Financial Results: Revenues, Losses, and Key Forward-Looking Statements - Minichart
H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $48 - Moomoo
NovoCure (NVCR) Q1 2026 Earnings Transcript - The Globe and Mail
NovoCure Limited (NVCR) Reports Strong Q1 2026 Results and FDA A - GuruFocus
Novocure (NVCR) Shares Jump 22% on Strong Q1 Revenue and Raised Outlook - GuruFocus
NovoCure (NASDAQ:NVCR) Shares Gap UpShould You Buy? - MarketBeat
NovoCure: Q1 Earnings Snapshot - theheraldreview.com
NVCR Stock Update: Insights on Current Market Trends - GuruFocus
Novocure (NVCR) Reports Strong Q1 Revenue Growth - GuruFocus
Novocure Jumps On Q1 Revenue Growth; Lifts FY26 Revenue Guidance - RTTNews
NovoCure (NVCR) Q1: EPS -0.62 (miss vs -0.51 est.), Revenue $174 - GuruFocus
NovoCure Reports Revenue Growth Driven by New Pancreatic Cancer Therapy - HarianBasis.co
NovoCure Q1 Earnings Call Highlights - MarketBeat
NovoCure Limited 2026 Q1ResultsEarnings Call Presentation (NASDAQ:NVCR) 2026-04-30 - Seeking Alpha
NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates - Yahoo! Finance Canada
NovoCure Ltd reports first quarter 2026 earnings performance - Traders Union
Novocure reports Q1 2026 revenue $174.1M, adjusted EBITDA $(0.3)M, net loss $71.1M - TradingView
Novocure (NASDAQ: NVCR) grows Q1 revenue and raises 2026 outlook - Stock Titan
NovoCure (NASDAQ: NVCR) grows Q1 2026 revenue while investing in new cancer indications - Stock Titan
New pancreatic cancer launch helps Novocure reach $174M in Q1 revenue - Stock Titan
Novocure earnings in focus as new pancreatic therapy debuts By Investing.com - Investing.com Nigeria
Novocure earnings in focus as new pancreatic therapy debuts - Investing.com UK
NovoCure (NASDAQ: NVCR) director converts options into 21,500 shares - Stock Titan
Vanguard (NVCR) holds 6.34M shares, 5.57% stake disclosed in 13G - Stock Titan
NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Earnings Preview: Novocure to Report Financial Results Pre-market on April 30 - Moomoo
CEO Frank Leonard's new NovoCure (NASDAQ: NVCR) contract outlines pay - Stock Titan
NovoCure (NVCR) to Release Quarterly Earnings on Thursday - MarketBeat
NovoCure Ltd (NVCR) Stock Up 6.5% and Still Undervalued -- GF Sc - GuruFocus
NovoCure : Financial Reports 2026 novocure corporate responsibility report - marketscreener.com
Total debt per share of NovoCure Ltd. – SWB:038 - TradingView
NovoCure Ltd stock (JE00B6T5S470): Is tumor treating fields therapy strong enough to unlock new upsi - AD HOC NEWS
[DEF 14A] NovoCure Ltd Definitive Proxy Statement - Stock Titan
NovoCure Ltd (MEX:NVCRN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
NovoCure Ltd stock (JE00B6T5S470): Does tumor treating fields therapy hold the key to oncology break - AD HOC NEWS
NovoCure Ltd (NVCR) Stock Up 3.8% and Still Undervalued -- GF Sc - GuruFocus
0.76%
0.72%
大文字化:
|
ボリューム (24 時間):